“microRNA-9-5p and its target nuclear factor kappa B are differentially expressed in type-2 diabetes patients”, Biomed. Res. Ther., vol. 11, no. 2, pp. 6183–6190, Feb. 2024, doi: 10.15419/bmrat.v11i2.863.